Breaking News Bar

Business News and Information

With fresh $155M round, Gilead's former top scientist moves forward with cancer-fighting startup

Kronos Bio plans to take its lead cancer drug into a pivotal trial next year.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
bottom clear